A Phase I Study of LJM716 in Squamous Cell Carcinoma of Head and Neck, or HER2+ Breast Cancer or Gastric Cancer

Clinical trial NCT01598077 · COMPLETED

Trial details

NCT number: NCT01598077
Sponsor: Novartis Pharmaceuticals
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

HER2 + Breast Cancer, HER2 + Gastric Cancer, Squamous Cell Carcinoma of Head and Neck, Esophageal Squamous Cell Carcinoma HER2 + Breast Cancer HER2 + Gastric Cancer Squamous Cell Carcinoma of Head and Neck Esophageal Squamous Cell Carcinoma

Start date: 2012-07-01
Primary completion: 2014-03-01
Enrollment: 54

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.